Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.

Suppr

超能文献

作者信息

Ganguly A, Grim C E, Weinberger M H

出版信息

N Engl J Med. 1981 Oct 22;305(17):991-3. doi: 10.1056/NEJM198110223051706.

DOI:10.1056/NEJM198110223051706

PMID:6268979

Abstract

摘要

相似文献

Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.

N Engl J Med. 1981 Oct 22;305(17):991-3. doi: 10.1056/NEJM198110223051706.

Glucocorticoid-suppressible hyperaldosteronism: a clue to the missing hormone?糖皮质激素可抑制性醛固酮增多症：缺失激素的线索？

N Engl J Med. 1981 Oct 22;305(17):1012-4. doi: 10.1056/NEJM198110223051712.

Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.地塞米松可抑制性醛固酮增多症：对肾上腺生理学的见解。

Adv Nephrol Necker Hosp. 1990;19:69-77.

Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.甲氧氯普胺和促肾上腺皮质激素对糖皮质激素可抑制性醛固酮增多症及其他形式醛固酮增多症患者血浆醛固酮水平的不同影响。

J Clin Endocrinol Metab. 1983 Aug;57(2):388-92. doi: 10.1210/jcem-57-2-388.

Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.

J Clin Endocrinol Metab. 1993 Sep;77(3):800-4. doi: 10.1210/jcem.77.3.8396580.

Dexamethasone-suppressible hyperaldosteronism: a large new kindred.

J Hum Hypertens. 1989 Aug;3(4):255-8.

[Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].

Minerva Endocrinol. 1992 Jan-Mar;17(1):43-6.

Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.长期使用地塞米松可纠正糖皮质激素可抑制性醛固酮增多症患者的高血压，并恢复醛固酮对肾素-血管紧张素的反应性。

Clin Exp Pharmacol Physiol. 1985 May-Jun;12(3):245-8. doi: 10.1111/j.1440-1681.1985.tb02640.x.

Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.

Acta Endocrinol (Copenh). 1989 Sep;121(3):334-44. doi: 10.1530/acta.0.1210334.

Long term evolution of glucocorticoid-suppressible hyperaldosteronism.糖皮质激素可抑制性醛固酮增多症的长期演变

J Clin Endocrinol Metab. 1987 Jan;64(1):22-6. doi: 10.1210/jcem-64-1-22.

引用本文的文献

Clinical and Molecular Perspectives of Monogenic Hypertension.单基因高血压的临床与分子视角

Curr Hypertens Rev. 2020;16(2):91-107. doi: 10.2174/1573402115666190409115330.

Glucocorticoid-remediable aldosteronism.糖皮质激素可治性醛固酮增多症

J Endocrinol Invest. 1995 Jul-Aug;18(7):512-7. doi: 10.1007/BF03349762.

Low-renin hypertension of childhood.儿童低肾素性高血压

Pediatr Nephrol. 1987 Jan;1(1):99-108. doi: 10.1007/BF00866890.

Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.地塞米松可抑制性醛固酮增多症：病理生理学、临床特点及发病机制的新见解

Klin Wochenschr. 1987 May 15;65(10):437-44. doi: 10.1007/BF01712834.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验